Metabolomics and network pharmacology reveal partial insights into the hypolipidemic mechanisms of ferulic acid in a dyslipidemia mouse model DOI Creative Commons
Zhihao Zeng, Guanlin Xiao, Yanchang Liu

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Сен. 20, 2024

Introduction Hyperlipidemia is a condition characterized by abnormal levels of lipids and lipoproteins in the plasma, posing significant health risks. Ferulic acid (FA) an organic with therapeutic properties for diabetes hyperlipidemia. Methods To explore biomarkers FA treatment hyperlipidemia elucidate mechanisms lipid-lowering-related changes metabolic pathways metabolomics network pharmacology. Initially, hyperlipidemic mouse model induced triton WR-1339 was established to evaluate effects FA. Subsequently, serum utilized identify differential metabolites, pathway analysis performed using MetaboAnalyst 6.0. Thirdly, pharmacology employed potential targets Finally, compound-target-metabolite (C-T-M) obtained core validated them molecular docking. Results Biochemical histological examination showed that had lipid-lowering on mice. It identified 31 against involving lipid amino metabolism. Lipid atherosclerosis signaling were as key KEGG analysis. Conjoint associated 18 six biomarkers. Molecular docking results has high binding affinity these targets. Discussion Through synergy metabolomics, this study provides insights into how regulates endogenous underscoring its promise

Язык: Английский

The interplay of gut microbiota, obesity, and depression: insights and interventions DOI Creative Commons
Iryna Halabitska, Pavlo Petakh, Iryna Kamyshna

и другие.

Cellular and Molecular Life Sciences, Год журнала: 2024, Номер 81(1)

Опубликована: Окт. 30, 2024

Язык: Английский

Процитировано

7

Effects of candidate genes on milk fat synthesis in ruminants: A meta-analysis DOI Creative Commons
Lily Liu,

W. Yan,

Min Yan

и другие.

Journal of Dairy Science, Год журнала: 2025, Номер unknown

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Phytochemical composition and antidiabetic, anti-obesity, antioxidant, and cytotoxic activities of Carthamus tinctorius seed oil DOI Creative Commons
Nidal Jaradat, Mohammed Hawash, Mustafa Ghanim

и другие.

Scientific Reports, Год журнала: 2024, Номер 14(1)

Опубликована: Дек. 28, 2024

Carthamus tinctorius L. (Safflower) is widely used in traditional Japanese, Korean, Chinese, Arabian, and Persian herbal medicine to treat metabolic diseases. This study aimed characterize C. seed oil components estimate its inhibitory effects on free radicals, porcine pancreatic lipase, α-amylase, cytotoxic. To describe the phytochemical of oil, Gas Chromatography-Mass Spectrometry (GC-MS) technique was performed, while reference biochemical analytical assays were utilized for biological testing. The results showed that seven fatty acids accounting 100% total identified, major acid linoleic (79.98 ± 0.79%), followed by oleic (11.20 0.21%) palmitic (5.71 0.12%) acids. tests revealed has potent with IC50 values 13.18 0.07, 43.6 0.09 31.62 0.65 μg/ml, respectively, comparison positive controls commercial drugs Trolox, Orlistat, Acarbose, which have 4.1 0.57, 12.88 0.94, 28.18 1.22 respectively. potential cytotoxic against tested cancer cells lines a concentration-dependent effect cell viability. Given these findings, it clear exhibits DPPH antilipase, α-amylase inhibitory, properties controls. Future vivo research warranted elucidate oil's mechanism action decipher molecular pathways involved anti-obesity, antidiabetic, antioxidant, activities.

Язык: Английский

Процитировано

1

Metabolomics and network pharmacology reveal partial insights into the hypolipidemic mechanisms of ferulic acid in a dyslipidemia mouse model DOI Creative Commons
Zhihao Zeng, Guanlin Xiao, Yanchang Liu

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Сен. 20, 2024

Introduction Hyperlipidemia is a condition characterized by abnormal levels of lipids and lipoproteins in the plasma, posing significant health risks. Ferulic acid (FA) an organic with therapeutic properties for diabetes hyperlipidemia. Methods To explore biomarkers FA treatment hyperlipidemia elucidate mechanisms lipid-lowering-related changes metabolic pathways metabolomics network pharmacology. Initially, hyperlipidemic mouse model induced triton WR-1339 was established to evaluate effects FA. Subsequently, serum utilized identify differential metabolites, pathway analysis performed using MetaboAnalyst 6.0. Thirdly, pharmacology employed potential targets Finally, compound-target-metabolite (C-T-M) obtained core validated them molecular docking. Results Biochemical histological examination showed that had lipid-lowering on mice. It identified 31 against involving lipid amino metabolism. Lipid atherosclerosis signaling were as key KEGG analysis. Conjoint associated 18 six biomarkers. Molecular docking results has high binding affinity these targets. Discussion Through synergy metabolomics, this study provides insights into how regulates endogenous underscoring its promise

Язык: Английский

Процитировано

0